Product Description
Long-Term Treatments of Anxiety Disorders is a celebration of the important advances made in the treatment of anxiety disorders since the 1970s. It is a unique resource that will enable the reader, regardless of theoretical or professional orientation, to develop an updated and balanced perspective on the psychological and pharmacological approaches to treating these disorders. The volume provides a critical appraisal of the long-term treatment of anxiety disorders and offers state-of-the-art recommendations for planning and implementing specific maintenance treatment strategies to ensure favorable long-term outcomes. Four general chapters present an overview of the epidemiology and natural course of the anxiety disorders, outline the basic mechanisms active in pharmacological and cognitive-behavioral treatments of these disorders, and extract lessons from the more advanced long-term treatment research literature on depressive disorders. The remaining 10 chapters are devoted to specific disorders and/or treatment modalities. Students who need to recognize the specific merits of psychological and pharmacological treatments of the anxiety disorders, clinicians who apply empirically validated treatment principles in their practices, and clinical researchers who recognize the challenge of developing a more robust foundation for optimal treatments all will find Long-Term Treatments of Anxiety Disorders to be an informative, stimulating, and practical resource.
About the Author
Matig R. Mavissakalian, M.D., is Professor in the Department of Psychiatry and Director of the Phobia and Anxiety Disorders Clinic at Ohio State University College of Medicine in Columbus, Ohio. Robert F. Prien, Ph.D., is Chief of the Clinical Treatment Branch at the National Institute of Mental Health in Rockville, Maryland.
